Search

everythinglearnresearchcommunity

for

Search:↓

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

The hepatitis B vaccine did not cause hair loss in the tested mice.

New physical methods like electrical currents, ultrasound, and microneedles show promise for improving drug delivery through the skin.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

Newborn skin is uniquely prepared to adapt to new environments compared to adult skin.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

The WNT signaling pathway is crucial for mesenchymal stem cells' function and therapy success.

A specific DNA region is crucial for Foxn1 gene expression in thymus cells but not in hair follicles.

Mesenchymal stem cell therapy may help treat alopecia areata by promoting hair growth and reducing inflammation.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Hair follicles are essential for skin health, aiding in hair growth, wound healing, and immune function.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Roxithromycin, an antibiotic, can increase hair growth and might be used as a treatment for hair loss.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Dengue virus can infect human hair follicle cells and may cause hair loss.

Follicular Cell Implantation might become a new treatment for hair loss and could lead to advances in organ regeneration.

StemMACS media is better for growing therapeutic stem cells than PowerStem media.

Fetal-maternal stem cells in a mother's hair can help with tissue repair and regeneration long after childbirth.

Plasma Rich in Growth Factors may help reduce hair loss in Frontal Fibrosing Alopecia.

Bacteria in our hair can affect its health and growth, and studying these bacteria could help us understand hair diseases better.

The S250C variant in a gene may cause autoimmunity and immunodeficiency by impairing protein function.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Some plant-based chemicals may help with hair growth, but more research is needed to confirm their effectiveness.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Epidermal stem cells have potential for personalized regenerative medicine but need careful handling to avoid cancer.